中文版 | English
题名

Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database

作者
通讯作者Li,Zhiwei
发表日期
2021-12-01
DOI
发表期刊
EISSN
1471-2407
卷号21期号:1
摘要
Background: Primary hepatic neuroendocrine tumors (PH-NETs) are extremely rare and unknown. Because of its rarity, its prognosis features and influencing factors are not well established. Methods: Data of 140 patients with PH-NETs diagnosed in the SEER database from 1975 to 2016 were collected. The demographics and clinic-pathological features were described. By using propensity-score matching (PSM) analysis, three associated cohorts were selected to describe the malignancy of PH-NETs and univariate analysis was conducted. Then, multivariate Cox analyses were performed and a predicting nomograph was constructed. C-index, receiver operating characteristic (ROC) curve and calibration curves were used to evaluate the predictive value of nomogram. Results: The overall survival outcomes of PH-NETs were superior to hepatocellular carcinoma (HCC) with a mean survival time 30.64 vs 25.11 months (p = 0.052), but inferior to gastrointestinal tract neuroendocrine tumors in situ (GI-NETs in situ) with a mean survival time 30.64 vs 41.62 months (p = 0.017). With reference to gastrointestinal neuroendocrine tumors with liver metastasis (GI-NETs-LM), GI-NETs-LM had better outcomes in short time (1-year survival rate: 64.75% vs 56.43%) but was worse in long time (5-year survival rate: 8. 63% vs 18.57%). Multivariate Cox analyses showed that tumor grade and surgery were two independent factors for prognosis of the patients (p < 0.00). Tumor grade and surgery were used to construct the predicting nomogram. The C-index was 0.79 (95%CI = 0.75–0.83). The area under curve (AUC) values in ROC were 0.868 in 1-year and 0.917 in 3-year survival and the calibration curves showed good consistency. Conclusions: The overall prognosis PH-NETs is generally favorable, better than HCC and GI-NETs-LM in long term. Preoperative biopsy and complete pathological diagnosis were recommended. Radical surgical intervention including transplantation was the first choice in PH-NETs therapy.
关键词
相关链接[Scopus记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
WOS记录号
WOS:000658351000001
ESI学科分类
CLINICAL MEDICINE
Scopus记录号
2-s2.0-85106191195
来源库
Scopus
引用统计
被引频次[WOS]:5
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/229466
专题南方科技大学第二附属医院
作者单位
1.Department of Hepato-Biliary Surgery,Shenzhen Third People’s Hospital,The Second Affiliated Hospital,Southern University of Science and Technology,Shenzhen,518055,China
2.Department of Ultrasonography,Shenzhen Third People’s Hospital,The Second Affiliated Hospital,Southern University of Science and Technology,Shenzhen,518055,China
3.Department of Hepatology,Beijing Hospital of Traditional Chinese Medicine,Capital Medical University,Beijing,China
4.Department of Lung Disease,Shenzhen Third People’s Hospital,The Second Affiliated Hospital,Southern University of Science and Technology,Shenzhen,518055,China
第一作者单位南方科技大学第二附属医院
通讯作者单位南方科技大学第二附属医院
第一作者的第一单位南方科技大学第二附属医院
推荐引用方式
GB/T 7714
Zhang,Ziteng,Zhao,Xin,Li,Zhiyan,et al. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database[J]. BMC Cancer,2021,21(1).
APA
Zhang,Ziteng.,Zhao,Xin.,Li,Zhiyan.,Wu,Youchun.,Liu,Yao.,...&Li,Guobao.(2021).Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.BMC Cancer,21(1).
MLA
Zhang,Ziteng,et al."Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database".BMC Cancer 21.1(2021).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Zhang,Ziteng]的文章
[Zhao,Xin]的文章
[Li,Zhiyan]的文章
百度学术
百度学术中相似的文章
[Zhang,Ziteng]的文章
[Zhao,Xin]的文章
[Li,Zhiyan]的文章
必应学术
必应学术中相似的文章
[Zhang,Ziteng]的文章
[Zhao,Xin]的文章
[Li,Zhiyan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。